Navigation Links
China Kangtai Cactus Biotech Announces Record Second Quarter Results
Date:8/15/2008

Revenue Increases 34% Driving Record Profitability

HARBIN, China, Aug. 15 /Xinhua-PRNewswire-FirstCall/ -- China Kangtai Cactus Biotech Inc. (the "Company") (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based consumer products in China, announced today record second quarter results for the period ended June 30, 2008. The Company reported revenue of $5.0 million, a 34.9% increase compared to $3.7 million in the 2007 second quarter. The increase in revenue was a result of growing acceptance of the Company's products such as Cactus Protein Nutrient, Cactus Calcium Peptide Soft Capsule and Cactus Shuxin Capsule by Chinese customers and expanded distribution.

Gross profit for the three months period ended June 30, 2008 was $1.5 million, an increase of 12.3% compared to $1.4 million for the same period last year. This increase was mainly attributable to the increase in net sales. For the three months ended June 30, 2008, pre-tax income increased by 10.2%, to $1.2 million from $1.1 million in the corresponding period of the prior year. Net income available to common stockholders increased to $1.0 million, or $0.06 per diluted share, compared to $0.9 million, or $0.05 per diluted share in the previous year's second quarter.

For the six months ended June 30, 2008, revenue increased 27.7% to $ 7.8 million, compared to $6.1 million in the corresponding period of the prior year. Pre-tax income increased 13.8% to $1.9 million for the 2008 first six months, compared to $1.7 million in the six months ended June 30, 2007. Net income increased to $1.6 million, compared to $1.4 million in the 2007 period ended June 30, 2007.

"Our second quarter results reflect the growing acceptance of our existing cactus products," said Jinjiang Wang, President of China Kangtai Cactus. "As we increase our marketing activities to support the recent launch of many of our exciting new products such as Cactus Cattle Feed and Cactus Fish Feed, we expect awareness of the health and productivity benefits of these products for livestock and fish to grow, leading to significant revenue growth."

About China Kangtai Cactus Biotech, Inc.

China Kangtai Cactus Biotech Inc. is market-leading cactus grower and producer of cactus-related products with over 387 acres of plants and an active R&D group that holds 17 product patents and is seeking another 13 in a variety of product categories. China Kangtai's high-quality products are sold throughout China in supermarkets, food stores, hotels and restaurants through a growing distribution network that has currently covered 12 provinces and 2 municipalities.

Cautionary Statement Regarding Forward-looking Information

This press release contains forward-looking information about China Kangtai Cactus Biotech that is intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology, and include discussions of strategy, and statements about industry trends and China Kangtai Cactus Biotech future performance, operations and products.

For more information, please contact:

Chengzhi Wang

General Manager

China Kangtai Cactus Biotech, Inc.

Tel: +86-158-0451-2893

Email: chinakangtai@gmail.com

Web: http://www.biocactus.com

Investor Relations:

Dan Schustack

CEOcast, Inc.

Tel: +1-212-732-4300

Email: dschustack@ceocast.com


'/>"/>
SOURCE China Kangtai Cactus Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China Biologic Products Reports Second Quarter 2008 Results
2. China-Biotics, Inc. Reports First Quarter 2009 Financial Results
3. China Sky One Medical, Inc. Develops Nasal Spray for Rheumatic Disease
4. China Bio Energy Holdings Group Reports Second Quarter 2008 Financial Results
5. China Biologic Products Establishes Governance and Nominating Committee and Compensation Committee
6. China Medicine Announces Strong Second Quarter 2008 Results
7. China Biologic Products Announces Second Quarter 2008 Results Conference Call
8. China Bionanometer Industries Corporation Promotes New Product Beauty Look in China
9. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
10. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
11. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Spain , Dec. 8, 2016  Anaconda BioMed ... the development of the next generation neuro-thrombectomy system for ... appointment of Tudor G. Jovin, MD to join its ... serve as a strategic network of scientific and clinical ... the development of the ANCD BRAIN ® to ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... launch of flexible packaging for their exceptionally efficient human mesenchymal stem/stromal cell ... RoosterBio’s portfolio of bioprocess media products engineered to radically streamline culture processes, ...
(Date:12/8/2016)... , ... December 08, 2016 , ... This CAST literature ... for biotech crops. The authors focus on the economic effects in countries that are ... of new biotech crops and the resultant risk of low level presence (LLP) puts ...
(Date:12/8/2016)... , Dec. 8, 2016 Soligenix, Inc. ... company focused on developing and commercializing products to treat ... announced today that it will be hosting an Investor ... ET on the origins of innate defense regulators (IDRs) ... review of oral mucositis and the recently announced and ...
Breaking Biology Technology:
(Date:11/17/2016)... CITY OF INDUSTRY, Calif. , Nov. 17, 2016  AIC announces that it ... about using NVMe storage servers in organizations that require high-performance scale-out plus high speed data transfer ... ... ... Setting ...
(Date:11/15/2016)... 15, 2016  Synthetic Biologics, Inc. (NYSE MKT: ... on the gut microbiome, today announced the pricing ... of its common stock and warrants to purchase ... price to the public of $1.00 per share ... from the offering, excluding the proceeds, if any ...
(Date:11/14/2016)... SARASOTA, Fla., Nov. 14, 2016  xG Technology, Inc. ... in providing critical wireless communications for use in challenging ... ended September 30, 2016. Management will hold a conference ... at 5:00 p.m. Eastern Time (details below). ... announced a $16 million binding agreement to acquire Vislink ...
Breaking Biology News(10 mins):